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ABSTRACT 
 In this study, I characterize the elements of the U2 snRNP that control its intranuclear 
trafficking and association with nascent transcripts.  Through a mutational analysis, I 
demonstrate that stem loops 3 and 4 (SL3 and SL4) are both required for U2 snRNP association 
with nascent transcripts and splicing speckles, while the Sm binding site is sufficient for U2 
snRNP association with Cajal bodies after nuclear entry.  For SL4, I further show that the 
associated protein U2B” rather than SL4 itself provides the targeting activity, which establishes a 
critical new role for U2B” in the pre-mRNA splicing pathway.  Additionally, I demonstrate that 
a lack of SL3, SL4, or U2B” results in an accumulation of the U2 snRNP within Cajal bodies.  
Collectively, my results support a paradigm where the recruitment of U2 snRNP to nascent 
transcripts is independent of its splicing activity and a model where Cajal bodies are domains 
that control snRNP assembly before association with nascent transcripts. 
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CHAPTER 1 
INTRODUCTION 
 
 In eukaryotes, pre-mRNA splicing is an essential step of gene expression that requires the 
five major small nuclear ribonucleoprotein particles: U1, U2, U4, U5 and U6 snRNPs.  Each 
snRNP consists of a small nuclear RNA (snRNA) and a specific set of associated proteins.  The 
snRNPs, along with a large collection other factors (100-300), assemble onto pre-mRNAs to 
form the spliceosome, the dynamic enzyme that excises introns and ligates exons to produce 
mature mRNAs (Jurica and Moore, 2003; Nilsen, 2003; Patel and Steitz, 2003; Zhou et al., 
2002).  The assembly of the spliceosome onto pre-mRNAs and the recognition of the correct 
exon-intron boundaries are directed by constitutive cis-acting elements: the 5’ and 3’ splice sites 
(5’SS and 3’SS), the A branchpoint site (BPS) and the polypyrimidine tract (Berget, 1995).  In 
addition, other regulatory sequences recognized by alternative splicing factors can control the 
selection of splice sites by the spliceosome combinatorially to increase the proteome diversity 
(Black, 2003; McManus and Graveley, 2011).  In the current view, pre-mRNA processing and 
transcription are coupled events (Bentley, 2005; de Almeida and Carmo-Fonseca, 2008; Martins 
et al., 2011).  Consistent with this paradigm, nascent RNA Polymerase II (RNAPII) transcripts 
accumulate snRNPs and other splicing factors, indicating that these factors are recruited prior to 
completion of RNA synthesis (Kim et al., 1997).  In addition, intron-containing RNAs that are 
transcribed by an RNAPII C-terminal domain (CTD) mutant are successfully capped but fail to 
recruit snRNPs and mature into mRNAs (Misteli and Spector, 1999). 
 SnRNPs are the catalytic components of the spliceosome and must undergo a complex 
maturation pathway prior to participating in spliceosomal assembly onto nascent transcripts 
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(Patel and Bellini, 2008).  Except for U6, snRNAs are transcribed by RNAPII as pre-snRNAs 
which are then actively exported to the cytoplasm where several maturation events occur: 3’ end 
cleavage, hypermethylation of the 5’monomethyl G cap into a trimethyl G cap, and association 
with a heteroheptameric (B/B’, D1, D2, D3, E, F, and G) complex of proteins known as the Sm 
ring (Raker et al., 1996).  The Sm ring and the trimethylated cap form a bipartite nuclear 
localization signal that promotes snRNP re-entry into the nucleus (Hamm et al., 1990), where 
snRNPs eventually acquire a specific set of proteins that are imported into the nucleus 
independently of their cognate snRNAs (Hetzer and Mattaj, 2000; Jantsch and Gall, 1992; 
Kambach and Mattaj, 1994).  Newly formed snRNPs display a complex choreography of 
interactions with several discrete nuclear domains, including Cajal bodies (CBs), nucleoli, 
splicing speckles or interchromatin granule clusters (IGCs), and eventually the sites of 
transcription by RNAPII.   
 After nuclear re-entry, newly formed snRNPs are first detected in CBs (Gall et al., 1999; 
Matera, 2003; Sleeman and Lamond, 1999) where they are likely to undergo internal 
modification (2’-O-methylation and pseudouridylation) and further assembly (Darzacq et al., 
2002; Jady et al., 2003).  In fact, CBs have been directly implicated in the final maturation steps 
of the U2 snRNP (Nesic et al., 2004; Tanackovic and Kramer, 2005), as well as in the assembly 
of the U4/U6.U5 tri-snRNP (Schaffert et al., 2004; Stanek and Neugebauer, 2004; Stanek et al., 
2003).  Additionally, SART3, the factor that promotes U4/U6 snRNP reassembly after splicing, 
is concentrated in CBs (Stanek et al., 2003).  CBs may not be the only sites of snRNP 
maturation, however.  Other domains such as nucleoli and the nucleoplasm are likely to 
contribute as well (Gerbi et al., 2003; Yu et al., 2001; (Zhao et al., 2002).  Only fully mature 
snRNPs are thought to later associate with IGCs (Sleeman and Lamond, 1999).  IGCs are highly 
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enriched in many splicing factors (Gall et al., 1999; Lamond and Spector, 2003), and in fact, 
proteomic analysis shows 81% of IGC proteins are implicated in RNA processing (Saitoh et al., 
2004).  This supports the current idea that IGCs may serve as repository sites of the pre-mRNA 
processing machinery from where it is recruited to nascent transcripts (Jimenez-Garcia and 
Spector, 1993; Nesic et al., 2004). 
 The lampbrush chromosomes (LBCs) of amphibian oocytes offer a unique opportunity to 
study the functional interactions of snRNPs with nascent transcripts in vivo at a very high spatial 
resolution (Morgan, 2002).  LBCs are highly extended diplotene bivalent chromosomes, and 
their characteristic resemblance to an oil-lamp or test-tube brush is due to each homologue 
consisting of a heterochromatin axis from which project numerous pairs of lateral loops.  These 
loops correspond to active RNAPII transcriptional sites and consist of euchromatin fibers 
surrounded by nascent RNP fibrils.  These RNP fibrils create a dense “RNP matrix” around the 
euchromatic axis of the loop.  Both loop domains (the chromatin axis and RNP fibrils) can be 
observed by light microscopy, and the highly decondensed chromatin axis can be demonstrated 
using antibodies directed against chromatin components such as histones or the RNAPII 
transcriptional machinery (Austin et al., 2009; Gall et al., 1999).  The RNP fibrils can be directly 
observed by both phase contrast and differential interference contrast microscopy.  In fact, it is 
often possible to witness transcription elongation along the axis of a loop because the RNP 
matrix adopts a thin to thick morphology.  Previously, our group proposed a model in which the 
recruitment of snRNPs to RNAPII nascent transcripts is independent from the co-transcriptional 
spliceosomal assembly (Patel et al., 2007).  This paradigm resulted from experiments showing 
that the major spliceosomal snRNPs are still recruited to LBC loops when splicing is inhibited or 
when the snRNPs themselves are non-functional.  Accordingly, I demonstrated that the first stem 
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loop of U1 snRNA is both necessary and sufficient for nascent transcript targeting.  Together, 
these results suggest a critical staging of the snRNPs directly onto the nascent RNP fibrils prior 
to spliceosomal assembly.   
 Here, I define the elements that control the intranuclear trafficking of the U2 snRNP.  In 
particular, I show that the Sm site is sufficient for association with CBs, while SL3 and SL4 are 
required for association with IGCs and nascent transcripts.  I also demonstrate that U2B” plays a 
critical role in the targeting of U2 snRNPs to nascent transcripts and that in the amphibian 
oocyte, U2B” appears to be a limiting factor in the assembly pathway of U2 snRNPs.  Last, I 
show that both newly formed U2 snRNPs and mutant U2 snRNPs that lack U2B” accumulate in 
CBs, directly supporting the current view that these subnuclear domains have a role in 
controlling the assembly of snRNPs. 
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CHAPTER 2 
MATERIALS AND METHODS 
 
DNA constructs   
 DNA templates for U2 snRNA and all U2 mutants were amplified from a Xenopus laevis 
U2 clone (Gall et al., 1999) using the high fidelity Deep VentR DNA Polymerase (New England 
Biolabs, Inc.), ethanol precipitated, and washed before use in transcription.  The bacteriophage 
MS2 coat protein cDNA was obtained from Dr. S Ceman (UIUC), the U2B” cDNA was obtained 
from Dr. J G Gall (Carnegie Institution).  DNA coding for U2B” and MS2 proteins were 
amplified as above and subsequently transformed into the vector pCR-Blunt II-TOPO 
(Invitrogen).   
 For U2 snRNA and associated mutants, the DNA primer (Integrated DNA Technologies) 
pairs used were as follows (T3 and T7 promoters are underlined):  
U2: (5’GCAATTAACCCTCACTAAAGGGATCGCTTCTCGGCCTTTTGGC and 
3’AAGTGCACCGGTCCTGGAGGTACTGC). 
U2Δ5’29 : (5’CGAATTAACCCTCACTAAAGGGAGTGTAGTATCTGTTCTTATC  and 
3’AAGTGCACCGGTCCTGGAGGTACTGC). 
U2Δ5’42 :(5’CGAATTAACCCTCACTAAAGGGTTCTTATCAGTTTAATATCTGA and 
3’AAGTGCACCGGTCCTGGAGGTACTGC). 
U2Δ5’-65  (5’CGAATTAACCCTCACTAAAGGGACGTCCCCTATCTGGGG and  
3’ AAGTGCACCGGTCCTGGAGGTACTGC). 
U2Δ5’84  (5’CGAATTAACCCTCACTAAAGGGCATATATTAAATGGATTTTTG 
GA and 3’AAGTGCACCGGTCCTGGAGGTACTGC). 
U2ΔBPS  (5’ATCGCTTCTCGGCCTTTTGGCTAAGATCAATGTTCTTATCAGTT 
TAATATCTG and 3’AAGTGCACCGGTCCTGGAGGTACTGC). 
U2Δ3’111  (5’GCAATTAACCCTCACTAAAGGGATCGCTTCTCGGCCTTTTGGC  
 and 3’TGTTCCAAAAATCCATTTAATAT). 
U2Δ3’146  (5’GCAATTAACCCTCACTAAAGGGATCGCTTCTCGGCCTTTTGGC and 
3’TGGAGTGGACAGAGCAAG). 
U2∆SL3  (Step 1: 5’GCAATTAACCCTCACTAAAGGGATCGCTTCTCGGCC 
TTTTGGC and 3’GCAATACCAGGTCGATGCGTGTTCCAAAAATCCAT 
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TTAATATATG; Step 2: 5’ GCAATTAACCCTCACTAAAGGGATCGCTTCT 
CGGCCTTTTGGC and 3’ AAGTGCACCGGTCCTGGAGGTACTGCAATA 
CCAGGTCGATGCGTGTTCC).  
 
U2B” was amplified with the following primer pairs (HA tag is in bold):  
HA-U2B” (5’TAGCCAGCCAGAACAATGGATATTCGGCCAAATCACACTGTC and 
3’CTAGGCATAGTCTGGGACGTCATATGGATATTTTTTAGCGAATG 
TAATTTTCATAGC).  
 
 The fusion clone HA-MS2-U2B” was constructed by ligating the cDNA coding for HA-
U2B” and MS2 binding protein at a newly introduced, unique SacII restriction site with a Fast-
Link DNA Ligation Kit (Epicentre Biotechnologies).   
 
In vitro transcription 
 Sense strand RNAs coding for U2B” and MS2 were transcribed with T3, T7, or SP6 
RNA polymerases (Stratagene) in the presence of 625 µM ATP, CTP, and UTP, 250 µM GTP, 
1.25 mM m7G(5’)ppp(5’)G cap analogue (New England Biolabs, Inc.), and recombinant RNasin 
Ribonuclease Inhibitor (Promega).  Reactions were incubated for 2 h at 37°C and were 
subsequently treated with RQ1 RNase-free DNase (Fisher Scientific) for 10 min at 37°C.  RNAs 
were phenol extracted, ethanol precipitated, washed, and resuspended in water.  Fluorescently 
labeled snRNA and mutants were transcribed as described above with the addition of 25 µM 
fluorescein-12-UTP (Roche) and UTP and GTP present at 312.5 µM.  Labeled RNAs were 
purified using NucAway Spin columns (Ambion) equilibrated with water. 
Oocytes and microinjection 
 Female adult Xenopus laevis were anesthetized in 0.15% tricaine methane sulfonate 
(MS222, Sigma-Aldrich), and fragments of ovary were biopsied.  Oocytes were defolliculated 
for 2 h at room temperature in saline buffer OR2 (Wallace et al., 1973) containing 0.2% 
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collagenase (type II, Sigma-Aldrich).  Stage IV-V oocytes were isolated and maintained in OR2 
at 18˚C.  All injections were performed under a dissection microscope (S; Leica) using an 
injector (Nanojet II, Drummond).   Glass needles were prepared with a horizontal pipette puller 
(P-97, Sutter Instrument Co.).  For all snRNA injections, ~10-20 fmol of the respective RNAs 
was cytoplasmically injected per oocyte.  For U2 snRNA depletion, 50 ng of the U2b DNA 
oligonucleotide (Integrated DNA Technologies) CAGATACTACACTTG (complimentary to 
residues 28-42 of U2 snRNA) were injected in the cytoplasm of oocytes. 
Nuclear spreads and immunofluorescence 
 Nuclear spreads were prepared as described previously (Patel et al., 2007).  Spreads were 
fixed in 2% paraformaldehyde in PBS + 1mM MgCl2 for 1 h at room temperature before rinsing 
in PBS, and blocking with 0.5% BSA (Sigma-Aldrich) + 0.5% gelatin (from cold water fish) in 
PBS for 10 min.  Nuclear spreads were incubated with primary antibody, washed with PBS (3 
times, 10 min each), incubated with secondary antibody, and washed again with PBS (3 times, 
10 min each).  Nuclear spreads were then mounted in 50% glycerol in PBS + 1mg/ml phenylene-
diamine and 10 pg/ml DAPI.  Fluorescence microscopy was performed using a fluorescent 
microscope (DMR; Leica), a PL Fluotar 40x NA 1.0 oil objective (Leica), and a Fluotar 100x 
NA 1.30 oil objective (Leica).  Images were captured with a Retiga EXI monochrome CCD 
camera (QImaging) and In Vivo software (version 3.2.0, Media Cybernetics), processed with 
Photoshop CS version 8.0 (Adobe), and assembled with InDesign CS version 3.0 (Adobe).  
 The following antibodies were diluted in blocking buffer and used for nuclear spreads at 
the indicated concentrations:  anti-HA mAb 3F10 (Roche, 50 ng/ml), anti-U2B” mAb 4G3 is a 
cell supernatant and was used at a 1:50 dilution, Alexa Fluor 488 anti-fluorescein/Oregon green 
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(Invitrogen, 2.5 µg/ml), Alexa Fluor 488 goat anti-mouse IgG (Invitrogen, 2.5 µg/ml), Alexa 
Fluor 594 goat anti-mouse IgG (Invitrogen, 2.5 µg/ml), and Alexa Fluor 488 goat anti-rabbit IgG 
(Invitrogen, 2.5 µg/ml). 
Coimmunoprecipitation and Western blotting 
 Expression of all HA-tagged proteins was accomplished by injecting 20-30 ng of the 
appropriate mRNA into Xenopus oocytes and incubating for 24-48 hrs.  20 oocytes, cytoplasmic 
fractions, and GVs were isolated using jeweler’s forceps, homogenized in 10mM Tris-HCl, pH 
8.0, 1 mM EDTA, and 0.2% SDS, and centrifuged at 22,000 g at 4°C for 10 min.  The 
supernatants were then collected and subjected to PAGE (Mini-PROTEAN 3; Bio-Rad 
Laboratories).  Immunoblotting was performed as described (Beenders et al., 2003) with the 
mAb anti-HA 3F10 at 50 ng/ml and alkaline phosphatase conjugated anti-rat IgG at 1:15,000.  
Coimmunoprecipitation was performed with Dynabeads Protein G (Invitrogen) equilibrated in 
5:1 buffer (Gall et. al, 1981) and coupled to the mAb anti-HA 3F10.  
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CHAPTER 3 
RESULTS 
 
Incomplete U2 snRNPs accumulate in Cajal bodies.   
 More than a decade ago, Gall et al. described how fluorescent U2 snRNAs injected into 
the cytoplasm of amphibian oocytes assemble into U2 snRNPs that rapidly become nuclear and 
accumulate in CBs.  In the same study, however, in situ hybridizations revealed that endogenous 
U2 snRNPs are present at very low concentrations in CBs (Gall et al., 1999).  Our group recently 
showed that in addition to accumulating in CBs, newly formed, fluorescent U2 snRNPs also 
rapidly associate with nascent transcripts and IGCs where they co-localize with the endogenous 
U2 snRNPs (Patel et al., 2007).  Here, I provide the first evidence that the newly formed, 
fluorescent U2 snRNPs that accumulate in CBs are incompletely assembled (Figure 1).  
Fluorescein-labeled U2 (fluo-U2) snRNAs were synthesized in vitro and injected into the 
cytoplasm of stage IV-V Xenopus oocytes.  Nuclear spreads were prepared 18 hours later and the 
distributions of newly formed U2 snRNPs and endogenous U2B” were monitored by 
fluorescence microscopy.  Newly formed U2 snRNPs were detected in the nucleus and 
associated with CBs, IGCs, and nascent transcripts.  Endogenous U2B” was associated with 
IGCs and nascent transcripts but was not associated with CBs, suggesting that the U2 snRNPs in 
CBs lack U2B” and may also lack other U2-specific factors.  In contrast, U2 snRNA and U2B” 
were colocalized in IGCs and on nascent transcripts, indicating that U2B” is likely a part of these 
U2 snRNPs (Figure 1).  In essence, at least two distinct populations of fluo-U2 snRNPs were 
observed: fully assembled U2 snRNPs containing U2B” that associated with IGCs and nascent 
transcripts, and U2 snRNPs that lack U2B” and were retained in CBs.  This observation suggests 
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a paradigm in which CBs would play an important role in controlling the proper assembly of 
snRNPs prior to IGC and nascent transcript targeting (Figure 2).  It also supports the idea that 
discrete elements of U2 snRNA, such as the binding site for U2B”, play important roles in the 
intranuclear fate of U2 snRNPs.  
 
Distinct elements of the U2 snRNP control its association with nascent transcripts, IGCs and 
CBs. 
 To gain insights into which domains of U2 snRNP are involved in regulating its 
intranuclear trafficking, I engineered a series of 5’ and 3’ truncations and internal deletions of the 
cDNA coding for the Xenopus laevis U2 snRNA (Summarized in Table I).  Corresponding, 
fluorescein-labeled RNAs were synthesized in vitro and injected into the cytoplasm of stage IV-
V Xenopus oocytes.  Fixed nuclear spreads were prepared 18 hours later, and the distribution of 
newly formed U2 snRNPs was monitored by fluorescence microscopy (Figure 3).  None of the 
deletions made upstream of the Sm site affected the targeting of the newly assembled U2 
snRNPs to LBC loops and IGCs (Table I, Entries 1-5).  For example, the longest 5’ deletion, 
U2∆5’84, removed the first three stem-loop structures SL1, SL2a and SL2b—nearly half of the 
U2 snRNA sequence; yet, U2∆5’84 RNA associated with LBC loops, IGCs and CBs (Figure 3).  
Qualitatively, these associations appeared as strong as those observed for newly formed, full-
length U2 snRNPs and had an identical LBC labeling pattern.  Because all of the 5’ deletion 
mutants lack a branchpoint sequence binding site and are therefore non-functional (Patel and 
Steitz, 2003), these results directly support my hypothesis that the recruitment of U2 snRNPs to 
nascent transcripts is independent from spliceosomal assembly.  In contrast, deletion of stem-
loop 3 (SL3) or 4 (SL4) had demonstrable effects on U2 snRNP intranuclear distribution:  both 
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deletions completely inhibited the recruitment of the mutant U2 snRNPs to nascent transcripts 
and IGCs (Figure 3).  Strikingly, like all of the 5’ end deletions, all of the 3’end deletion mutants 
of U2 snRNA, including the U2∆3’111 RNA that contains only five nucleotides downstream of 
the Sm binding site, were still able to associate with CBs.  This strongly suggests that the Sm site 
is required to control the association of U2 snRNPs with CBs.   
 To test whether the Sm site would act autonomously to drive RNAs to CBs, I generated a 
chimeric RNA, pBS-U2Sm, composed of the U2 Sm site fused to an unrelated, 119-nucleotide 
RNA derived from the plasmid pBluescript (Figure 4).  The pBS-U2Sm RNA was injected into 
the cytoplasm of stage IV-V oocytes, and its subnuclear distribution was defined 18 hours later 
on fixed nuclear spreads.  As expected of a U2-derived RNA lacking SL3 and SL4, pBS-U2Sm 
was not targeted to the IGCs and LBC loops.  However, pBS-U2Sm accumulated within CBs at 
high concentrations, and CBs were the only structures showing fluorescence (Figure 4).  This 
result demonstrates that the Sm binding site and associated Sm proteins are sufficient to promote 
the association of RNAs within CBs.   
 
U2B” targets IGCs and nascent transcripts only when part of a U2 snRNP.   
 My deletion analysis of the U2 snRNA revealed SL3 and SL4 as elements that are critical 
for the recruitment of U2 snRNPs to IGCs and nascent transcripts.  SL4 is a well-known binding 
site for two proteins, U2A’ and U2B”.   Both proteins can associate to form a heterodimeric 
complex, and this interaction is critical for the specific binding of U2B” to SL4 of U2 snRNA 
(Scherly et al., 1990).  To better understand the mechanisms by which the SL4/U2A’/U2B” 
element is involved in targeting U2 snRNPs to nascent transcripts, I analyzed the intranuclear 
distribution of U2B” using nuclear spreads (Figure 5).  Capped transcripts coding for HA-U2B” 
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were synthesized in vitro and injected into the cytoplasm of stage IV-V oocytes.  Nuclei were 
isolated 18 h later for nuclear spreads, and HA-U2B” proteins were detected using the anti-HA 
mAb 3F10.  Nucleoli were the only structures where HA-U2B” could be detected (Figure 5A); 
this was in striking contrast to the localization of endogenous U2B” on nascent transcripts and in 
IGCs when assayed in untreated oocytes (Patel et al., 2007).  In fact, the distribution of HA-
U2B” was identical to that of the endogenous U2B” in oocytes where an anti-sense DNA 
oligonucleotide targeted RNAse H-mediated degradation of U2 snRNA (Figure 5 and (Patel et 
al., 2007).  Finally, an incubation of more than 48 hours post-injection was necessary to reveal a 
very weak association of HA-U2B” with IGCs and nascent transcripts (Data not shown).  Based 
on these data, I hypothesized that newly expressed HA-U2B” cannot associate with endogenous 
U2 snRNPs, presumably because of a stable complex between SL4 and endogenous U2B”.  Why 
free HA-U2B” accumulates in nucleoli is still not clear, however.  
 To test this hypothesis, full-length fluo-U2 snRNA was injected into oocytes already 
expressing HA-U2B”, and nuclear spreads were prepared 18 h later (Figure 5B).  As expected, 
fluo-U2 snRNPs associated with IGCs and LBC loops.  Remarkably, fluo-U2 snRNA was 
sufficient to drive HA-U2B” out of nucleoli—these structures were largely devoid of 
fluorescence.  Instead, HA-U2B” associated with IGCs and LBC loops where it displayed 
extensive co-localization with fluo-U2 snRNA (Figure 5B).  I conclude that in absence of an 
association with U2 snRNA, U2B” does not target IGCs or LBC loops.   These results also 
suggest that there is little exchange between snRNP-associated U2B” and free HA-U2B”.  
Interestingly, both HA-U2B” and fluo-U2 snRNA were only weakly detected in CBs; this was in 
sharp contrast with the strong fluorescent signal in CBs when only fluo-U2 snRNA was injected 
(Figure 1).  These results further support the idea that there is a limiting amount of free U2B” in 
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the oocyte’s nucleus.  Consequently, when fluo-U2 snRNA is injected, there is not enough free 
nuclear U2B” to associate with every newly formed fluo-U2 snRNP, and the excess accumulates 
in CBs as incompletely assembled U2 snRNPs.  When more U2B” is made available in the form 
of an exogenous HA-U2B”, most newly formed U2 snRNPs can associate with HA-U2B” and 
target IGCs and nascent transcripts rather than accumulating in CBs. 
 
U2B” is a limiting factor that is essential but not sufficient for targeting U2 snRNPs to 
nascent transcripts.   
 As mentioned previously, depletion of U2 snRNA using RNase H-mediated degradation 
with anti-sense DNA oligonucleotides results in a release of U2B”, which then accumulates 
within nucleoli (Patel et al., 2007).  To further investigate the concept of a limiting U2B” protein 
in the assembly of U2 snRNPs, I tested if increasing the level of free endogenous U2B” in the 
nucleus affected the accumulation of fluo-U2 snRNPs within CBs or the targeting of fluo-U2 
snRNPs to nascent transcripts (Figure 6).  Stage IV-V oocytes were first injected with the U2-
depleting DNA oligonucleotide U2b, and fluo-U2 snRNA, fluo-U2∆SL3 or fluo-U2∆SL4 were 
injected 18 h later.  After a final 18 hours of incubation, nuclear spreads were prepared, and the 
newly formed fluo-snRNPs as well as the endogenous U2B” were detected by 
immunofluorescence.  In nuclear spreads of both full-length U2 and U2∆SL3 snRNAs, which 
contain the U2B” binding site SL4, U2B” was not detected in nucleoli.  Instead, in both cases, 
U2B” was found precisely colocalized with the newly formed snRNPs.   U2 snRNPs were found 
primarily associated with IGCs and nascent transcripts, while U2∆SL3 snRNPs were found 
exclusively in CBs (Figure 6, U2 snRNA and U2∆SL3).  With U2∆SL4 snRNA, however, U2B” 
remained in nucleoli and U2∆SL4 snRNPs accumulated in CBs (Figure 6, U2∆SL4).  These data 
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indicate the following: 1) Even with excess U2B” available, U2∆SL4 snRNPs fail to target IGCs 
and nascent transcripts; 2) U2B” is not sufficient for IGC and nascent transcript targeting 
because U2∆SL3 still binds U2B” but both accumulate within CBs; 3) The accumulation of fluo-
U2 snRNPs in CBs when fluo-U2 snRNA is microinjected into normal oocytes (Figure 1) is due 
to a lack of available U2B” during snRNP assembly.  
 
SL4 acts in IGC and nascent transcript targeting by recruiting U2B” to the U2 snRNP.   
 Free U2B” did not target nascent transcripts autonomously but rather accumulated in 
nucleoli.  Therefore, I decided to investigate whether SL4 plays any role, other than being a 
binding site for U2B”, in the intranuclear trafficking of the U2 snRNP.  In particular, I wanted to 
investigate whether the deletion of SL4 impacts the overall architecture of the U2 snRNP beyond 
the loss of U2B”, which could explain the inability of the U2∆SL4 snRNP to target IGCs and 
nascent transcripts (Figure 1).  To do so, I replaced the 13 residues (5’-UAUUGCAGUACCU-
3’) forming the loop of SL4 with 5’-UUCG-3’.  This nucleotide substitution is sufficient to 
maintain the stability of any stem-loop structure (Ennifar et al., 2000; Jarmolowski and Mattaj, 
1993).  It should also prevent the binding of U2B” to the modified SL4 because this interaction 
occurs primarily through residues 166 and 168 (Scherly et al., 1990).  Fluorescent U2-
L4(UUCG) RNA was synthesized and injected into the cytoplasm of stage IV-V oocytes and 
nuclear spreads were prepared 18 h later.  Newly formed U2-L4(UUCG) snRNPs accumulated in 
CBs but did not associate with IGCs or nascent transcripts (Figure 7; Table I). Importantly, 
U2B” was absent from CBs, suggesting U2-L4(UUCG) could not interact with U2B”.  When 
HA-U2B” was injected into the same oocytes as U2-L4(UUCG) snRNA, HA-U2B” accumulated 
in nucleoli and was unable to co-localize with U2-L4(UUCG), which still accumulated only in 
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CBs (Data not shown).  Together, these data suggest that the role of SL4 in the intranuclear 
trafficking of U2 snRNP is presumably limited to the recruitment of U2B”.   
 To test this hypothesis, I used the bacteriophage MS2 coat protein and RNA binding site 
system to artificially tether U2B” to a U2 snRNP in absence of SL4.  A new chimeric RNA, 
U2∆SL4-MS2 RNA, was generated by substituting SL4 with another short RNA stem-loop 
corresponding to the binding site for the viral coat protein MS2.  When injected into oocytes and 
assayed on nuclear spreads, the U2∆SL4-MS2 RNA targeted CBs but not LBC loops (Figure 8A; 
Table I).  This result was expected because U2∆SL4-MS2 RNA possesses the Sm binding site, 
but lacks SL4.  In addition, I found that a fusion protein composed of the MS2 viral coat protein 
and U2B”, HA-MS2-U2B”, localizes exclusively to nucleoli (Figure 8B), showing that the 
addition of the MS2 protein to HA-U2B” does not influence its subnuclear distribution. Finally, 
U2∆SL4-MS2 snRNA was injected in oocytes already expressing the fusion protein HA-MS2-
U2B”, and nuclear spreads were prepared 18 h later (Figure 8C).  Remarkably, the U2∆SL4-
MS2 snRNA targeted CBs, IGCs and nascent transcripts, and precisely colocalized with the HA-
MS2-U2B” fusion protein.  In addition, similarly to U2B”, the HA-MS2-U2B” fusion protein 
targeted nascent transcripts only when associated with U2 snRNPs (Figure 8C; Table I).  
Together, these data demonstrate that U2B”, not its RNA-binding site SL4, induces U2 snRNPs 
to target IGCs and nascent transcripts.  
 
The U2∆SL4 snRNP can act in co-transcriptional splicing when U2B” is artificially tethered 
to it.   
 My group previously showed that spliceosomal activity is present on the LBC loops by 
monitoring the association of the protein Y14, a core component of the Exon Junction Complex 
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(EJC), with nascent transcripts in presence or in absence of U2 snRNA (Patel et al., 2007). 
Deposition of EJCs on nascent transcripts occurs 24 nucleotides upstream of a junction between 
two exons and is required for spliceosomal activity (Bono and Gehring, 2011).  We also took 
advantage of this assay to demonstrate that fluo-U2 snRNA can rescue co-transcriptional splicing 
activity in U2 snRNA-depleted oocytes (Patel et al., 2007).  In this study, I used the same assay 
to determine if various U2 snRNA mutants could engage in splicing activity (Figure 9A and S2).  
U2 snRNA was depleted from stage IV-V oocytes, and fluo-U2 snRNA mutants were assayed 
for their ability to rescue the recruitment of endogenous Y14 to nascent transcripts. Wild-type 
U2 snRNA was used as a positive control.  Results are summarized in Table I.  A truncation of 
SL1, the first 29 nucleotides in the 5’ region of U2 snRNA, was sufficient to completely inhibit 
the co-transcriptional splicing activity of U2 snRNPs (Figure S2).  All other truncations or 
deletions upstream of the Sm binding site showed the same phenotype (Table I).  In addition, 
because a lack of SL3 or SL4 prevented the recruitment of U2 snRNPs to nascent transcripts, I 
expected that U2∆SL3 or U2∆SL4 would not rescue the recruitment of Y14 to LBC loops  
(Table I).  An earlier study, however, demonstrated that SL4 is dispensable for the splicing 
activity of U2 snRNP when both U2∆SL4 snRNA and an RNA splicing reporter were co-
injected into the oocyte’s nucleus (Pan and Prives, 1989).  Therefore, I tested whether 
spliceosomal activity on LBC loops could be rescued by the chimeric U2∆SL4-MS2 RNA in 
oocytes expressing the MS2-U2B” fusion protein (Figure 9).  Interestingly, Y14 was recruited to 
nascent transcripts as efficiently as when splicing activity was assayed using full-length U2 
snRNA, the positive control (Figure 9C).  This result suggests that while U2B” is not needed for 
the inherent splicing activity of the U2 snRNP, it is required for the U2 snRNP to engage 
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splicing co-transcriptionally.  Collectively, these data support a paradigm where the recruitment 
of snRNPs to nascent transcripts occurs in a splicing-independent mechanism. 
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CHAPTER 4 
DISCUSSION 
 
 One of the most prominent characteristics of the cell nucleus that has emerged over the 
last two decades is its functional organization into many discrete domains.  While the functions 
of some of these domains, such as the nucleolus, are well characterized, much remains to be 
learned regarding the roles of most nuclear bodies in orchestrating nuclear activities.  A major 
challenge in studying nuclear bodies is that their function is primarily inferred from their 
molecular composition, which can vary during the cell cycle and among various cell types, rather 
than from specific enzymatic reactions associated with these domains.  For example, CBs were 
previously defined in amphibian oocyte nuclei based on their molecular composition, but recent 
insights from Nizami et al. suggest that these domains may be more accurately defined as histone 
locus bodies (Nizami et al., 2010).  Nevertheless, characterizing the steady-state composition of 
subnuclear bodies can still provide useful clues in interpreting the functions of these domains.  
The localization of snRNPs to various nuclear bodies has been well documented, but the 
regulation of how snRNPs traffic among intranuclear domains during their maturation is not well 
understood.  In this study, I use the oocyte from X. laevis to characterize the elements of the U2 
snRNP that influence its interactions with CBs, IGCs, and nascent transcripts.  My data provide 
further evidence that CBs are a site of assembly control for snRNP maturation and that discrete 
elements of snRNPs can regulate snRNP subnuclear trafficking. 
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CBs may act as a site of assembly control for U2 snRNP.    
 CBs are sites where important maturation events of the spliceosomal snRNPs may occur.  
In my model, CBs would also act in a regulatory role to prevent incompletely assembled snRNPs 
from associating with IGCs and nascent transcripts (Figure 2).  Accordingly, I see an 
accumulation of fluo-U2 snRNPs lacking U2B” (Figure 1) and U2 snRNP mutants lacking SL3, 
SL4 or both (Figures 3 and 7) in CBs; this accumulation may indicate that in absence of U2B” or 
SF3a (the U2 snRNP-specific protein that binds to SL3), the splicing-competent 17S U2 snRNP 
cannot be formed.  Further data supporting this role for CBs shows that when HA-U2B” and 
fluo-U2 snRNA are co-expressed in oocytes, they colocalize in IGCs and on nascent transcripts 
but are not detected in CBs (Figure 5).  When taken together, these data strongly suggest that 
newly formed U2 snRNPs accumulate in CBs if incompletely assembled and remain associated 
with CBs until they are fully assembled.  Previous experiments have shown this to hold true for 
the U1 snRNP as well.  The U1 snRNP is normally absent from CBs in stage IV-V oocytes, but 
rapidly accumulates in CBs upon truncation of the first stem-loop structure (U1SL1) of U1 
snRNA (Gall et al., 1999) via RNase H-mediated degradation.  Subsequently, I showed that a 
U1∆SL1 mutant also localized solely in CBs, and therefore U1SL1, most likely through 
interactions with the proteins U170K and U1C, is both necessary and sufficient for targeting U1 
snRNP to IGCs and nascent transcripts. 
 Once U2 snRNPs are matured and able to assemble into spliceosomes, they associate 
with IGCs and nascent transcripts.  Here, I show that both SL3 and SL4 of U2 snRNA are 
required for the association of U2 snRNP with IGCs and nascent transcripts (Figure 3 and Figure 
6), and that SL4 is dispensable for correct intranuclear trafficking if the SL4-associated protein 
U2B” is artificially tethered to U2 snRNP (Figure 8).  While I did not explore the possible role of 
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SF3a, it is likely to act in synergy with U2B”.  This conclusion is substantiated by the deletion of 
SL3 completely inhibiting the targeting of U2 snRNP to IGCs and nascent transcripts.  A 
previous study suggested that the lack of SL3 may destabilize the binding of U2B” to SL4 
(Scherly et al., 1990).  However, Figure 6 shows that U2∆SL3 snRNP still binds U2B”, and the 
complex accumulates in CBs.  Thus, while the deletion of SL3 does not prevent the association 
of U2B”, it still prevents the correct targeting of U2 snRNPs to IGCs and nascent transcripts.   
 Binding of SF3a is essential in forming the mature, 17S U2 snRNP (Kramer et al., 1999; 
Nesic et al., 2004).  Despite the role of CBs in snRNP maturation and assembly, endogenous 
SF3a is not detected in CBs at steady state.  Instead, SF3a accumulates in speckles (Nesic et al., 
2004; Tanackovic and Kramer, 2005), suggesting that mature U2 snRNPs quickly end their 
association with CBs and are driven to speckles.  Whether the acquisition of SF3a by U2 snRNP 
occurs in CBs or in another nuclear domain is not clear, and remains difficult to test because of 
the rapid exchange of snRNPs between CBs and the nucleoplasm.  Tanackovic and Kramer also 
found that in SF3a depleted cells, U2 snRNA and U2B” are no longer found in speckles but 
instead accumulate in CBs, likely indicating that U2 snRNPs lacking SF3a are incompletely 
assembled and are unable to associate with speckles even when U2B” is present.  These studies 
are in agreement with my results showing that the deletion of either SL3 or SL4 results in the 
inability of U2 snRNP to associate with IGCs and nascent transcripts, and therefore, U2B” and 
SF3a are both required and act synergistically to target U2 snRNPs to IGCs and nascent 
transcripts. 
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The Sm site/Sm ring directs snRNP association with CBs.   
 Several studies have demonstrated that the snRNA component of snRNPs is modular and 
that each module can have its own distinct function in intranuclear trafficking.  As mentioned 
above, our group previously demonstrated that U1SL1, presumably in concert with its associated 
proteins U1C and U1-70K, was both required and sufficient for nascent transcript targeting 
(Patel et al., 2007).   The snRNA elements required for the association of the non-splicing U3 
snRNPs with nucleoli were identified and termed nucleolar localization elements (NoLEs) 
(Lange et al., 1998), and the Sm site was shown to be necessary and sufficient for targeting of 
U7 snRNA to CBs (Wu et al., 1996).  In this study, the targeting of a pBS-U2Sm chimeric RNA 
to CBs indicates that the Sm site is also sufficient for the accumulation of U2 snRNA within 
CBs. I also obtained identical data using the U1 Sm site (Table I).  The pBS-U2Sm RNA 
contains only the 9 nucleotides of U2 snRNA corresponding to the Sm binding site.  The only 
proteins directly associated with the pBS-U2Sm RNA in the nucleus, therefore, are the Sm 
proteins; as a result, they are directly implicated in targeting the pBS-U2Sm RNA to CBs.  Two 
potential mechanisms may explain this.  First, coilin, the typical marker for CBs, directly 
interacts with SMN (Hebert et al., 2001).  SMN assembles the SM ring onto snRNAs in the 
cytoplasm, and remains associated with snRNPs during nuclear import and in the nucleus 
(Narayanan et al., 2004).  Thus, the SMN-coilin interaction may facilitate the localization of Sm 
snRNPs to CBs upon nuclear re-entry.  Second, coilin may directly interact with SmB’, and this 
interaction may act to bring snRNPs to CBs (Bellini and Gall, 1999; Narayanan et al., 2004; 
Tucker et al., 2001).   
 It is equally likely, however, that snRNPs do not display a genuine CB targeting signal.  
CBs were previously described as “sponge-like” structures because large, fluorescent dextran 
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complexes could readily diffuse through them.  FRAP on fluorescently labeled snRNAs showed 
that snRNPs exhibit a dynamic exchange between CBs and the nucleoplasm (Handwerger et al., 
2005).  SnRNPs, therefore, may enter CBs by random diffusion, and the Sm complex could act 
as a retention domain whose role would be to merely increase the residence time of snRNPs 
within CBs to promote maturation events occurring there.  My proposed model (Figure 2) allows 
for snRNP maturation or recycling to occur not only in CBs but also in other domains such as the 
nucleoplasm and the nucleolus (Yu et al.; Zhao et al., 2002).   
 A model where the Sm site is responsible for snRNP association with CBs contrasts with 
a recent study showing that a pre-U snRNA lacking the Sm binding site still targets CBs when 
the mutant pre-U snRNA is injected into the nucleus of a Xenopus oocyte (Suzuki et al., 2010).  
This discrepancy almost certainly arises because pre-U snRNAs and processed U snRNAs 
associate with distinct protein complements.  Indeed, the presence of pre-U snRNAs in CBs was 
correlated with the formation of an active export complex at the 5’ monomethyl guanosine cap 
(Izaurralde et al., 1995a; Izaurralde et al., 1995b).  Once in the cytoplasm, however, the export 
complex is disassembled, the RNA acquires the Sm proteins, and the 5’ monomethyl guanosine 
cap is hypermethylated into a 5’ trimethyl guanosine G cap that serves as a nuclear import signal 
for the adapter protein snurportin 1 (Rollenhagen and Pante, 2006).   
 
The recruitment of U2 snRNP to nascent transcripts is splicing-independent and relies on SL3 
and SL4.   
 The critical residues of SL4 involved in the binding of U2B” were previously 
characterized (Scherly et al., 1990).  Since then, the specific binding of U2B” to SL4 has since 
been used extensively as a system to examine protein/RNA interactions (Guo and Gmeiner, 
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2001; Price et al., 1998; Williams and Hall, 2011).  As a result, detailed information on the 
SL4/U2B” complex exists, and for this reason, in the current study I focused my attention on the 
SL4/U2B” complex rather than on the less-characterized SL3/SF3a complex.  After discovering 
the phenotype observed with deletion of U2SL4, I concentrated my subsequent analyses on 
U2B” because U2A’ is usually described as the auxiliary protein that provides binding 
specificity to U2SL4 (Scherly et al., 1990).  In addition, HA-U2B” associates with IGCs and 
nascent transcripts when exogenous U2 snRNA is provided (Figure 5), likely indicating that free 
U2A’ is available for the proper assembly of U2 snRNPs.  Similarly, free SF3a is also almost 
certainly available in the oocyte nucleus to associate with newly assembled U2 snRNPs.  Unlike 
U2A’ and SF3a, U2B” is a limiting factor for U2 snRNP assembly because its addition alone can 
drive incomplete U2 snRNPs from CBs to IGCs and nascent transcripts (Figure 1 and Figure 5).  
U2B” exhibits two RNA Recognition Motifs (RRM): RRM1 and RRM2.  While RRM1 is 
known to interact with specific residues of SL4 (Price et al., 1998; Scherly et al., 1990), the role 
of RRM2 is still unknown.  In the light of my current data, I hypothesize that RRM2 is involved 
in interacting either directly with nascent transcripts or with factors associated with the nascent 
RNP fibrils.  However, U2B” cannot be described as a simple molecular bridge because it is 
required but not sufficient to interact with nascent transcripts.  In fact, U2B” acquires its role in 
directing the late events of U2 snRNP intranuclear trafficking only when bound to SL4, perhaps 
as a result of a conformational change or an interaction with SF3a.  I base this conclusion on two 
pieces of evidence.  First, U2∆SL3 binds U2B”, but fails to target IGCs and nascent RNP fibrils 
(Figure 6).  Thus, U2B” is required but not sufficient for the interaction of U2 snRNP with IGCs 
and nascent transcripts.  Second, in absence of U2 snRNA, U2B” loses its ability to interact with 
IGCs and nascent RNP fibrils and relocalizes to nucleoli (Patel et al., 2007).  The reason for this 
  24 
nucleolar relocalization is not clear, but two possible explanations may explain it.  One 
interpretation is that, in absence of its specific RNA target, U2B” associates non-specifically 
with RNA-rich domains, such as nucleoli.  Another explanation is that, in Xenopus oocytes, 
nucleoli may represent sites of U2 snRNP maturation. 
 U2B” acquires its IGC and nascent transcript targeting properties via a mechanism that is 
more than just a direct consequence of U2B” binding to SL4 because the artificial tethering of 
U2B” to the U2 snRNP is sufficient to rescue the correct intranuclear trafficking of U2∆SL4 
snRNPs.  Interestingly, I show in Figure 9 that U2∆SL4-MS2/MS2-U2B” snRNPs also rescue 
the recruitment of Y14 to LBC loops in U2 snRNA-depleted oocytes, indicating that U2∆SL4-
MS2/MS2-U2B” snRNPs participate in spliceosomal assembly and activity on nascent 
transcripts.  In addition, this result shows that SL4 itself is not required for splicing and is 
consistent with previous results showing that U2∆SL4 can perform its spliceosomal function 
when it is directly co-injected with an RNA splicing reporter in the nucleus of U2 snRNA 
depleted oocytes (Pan and Prives, 1989).  Taken together, these data strongly suggest a novel 
role for U2B” in intranuclear trafficking.  U2B” may not be required for spliceosomal activity, 
but it plays a critical role in the recruitment of U2 snRNP to nascent RNP fibrils, a pre-requisite 
for co-transcriptional splicing to occur. 
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CHAPTER 5 
CONCLUSIONS 
 
 The regulation of snRNP intranuclear trafficking is a critical aspect in understanding the 
maturation pathway of snRNPs before they participate in pre-mRNA splicing.  SnRNPs travel 
through distinct subnuclear domains before being recruited to nascent transcripts and assembling 
into the spliceosome, and while some studies have begun to describe the elements that regulate 
this process, much still remains to be discovered.  In this study, I showed that U2B” plays a 
unique role in bringing the U2 snRNP to nascent transcripts.  These results support my group’s 
previous findings for the U1 snRNP.  In that study, we showed that SL1 of U1 snRNA was 
responsible for the nascent transcript targeting of the U1 snRNP.  Since this region does not 
hybridize to pre-mRNA—the 5’ splice site-binding element does this—we hypothesized that U1-
70k acted as a bridge protein between nascent pre-mRNA fibrils and the U1 snRNP.  This 
situation is analogous to what I have shown here; the U2 snRNP is likely brought to nascent 
transcripts by U2B”. When taken together, we begin to see a general trend in which specific 
snRNP proteins, such as U2B” and U1-70k, play a critical role in the recruitment of snRNPs to 
nascent transcripts prior to their assembly into the spliceosome.  This model is in contrast to the 
current model that states that snRNPs first contact splice sites through hybridization to pre-
mRNA.  Given that our non-functional U1 and U2 snRNPs were still localized to nascent 
transcripts, this new model must be taken into account. 
 Here, I also proposed that CBs act as an assembly control checkpoint during the 
maturation of the U2 snRNP.  This result complements other studies that showed the CB to be a 
site of biochemical modification, assembly, and maturation of the U2 snRNP.  In my model, the 
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CB would also act to prevent the transit to nascent transcripts of snRNPs that are not fully 
assembled.  As a whole, we see that the CB plays an increasingly important role in regulating the 
recruitment of fully mature snRNPs to IGCs and nascent transcripts.  I also showed that the Sm 
site acts as a CB targeting element.  This result helps us understand how snRNPs are trafficked 
within the nucleus just after nuclear re-entry.  At this point, the only proteins bound to Sm-
snRNPs are the Sm proteins; therefore, showing that the Sm site was capable of targeting an 
unrelated RNA to CBs was an expected yet exciting result. 
 Because the functional element of the U2 snRNP, the BPS binding element, lies well 
outside of the U2B”/SL4 region that is responsible for recruitment to nascent transcripts, these 
results also support my main hypothesis that snRNP spliceosomal function and recruitment to 
nascent transcripts are independent from one another.  In this model, snRNPs are first recruited 
to nascent transcripts through an interaction with mRNP fibrils, and only when spliceosomal 
function is required do snRNPs then assemble into the spliceosome (Figure 10).  The 
independence of snRNP recruitment and assembly into the spliceosome may therefore be an 
important feature in the regulation of pre-mRNA splicing. 
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FIGURES AND TABLES 
 
 
Figure 1. Incompletely assembled U2 snRNPs lack U2B” and accumulate in CBs, while 
fully assembled U2 snRNPs target IGCs and nascent transcripts.  Differential interference 
contrast (DIC) and corresponding fluorescent micrographs of nuclear spreads prepared from 
stage IV-V Xenopus laevis oocytes.  Oocytes were injected in the cytoplasm with in-vitro 
transcribed, fluorescein-UTP labeled U2 snRNA, and nuclear spreads were prepared 18 hours 
later.  Fluorescent U2 snRNA (fluo-U2) is shown in green.  U2B” is detected using the 
monoclonal antibody mAb 4G3 and is shown in red.  DNA is counterstained with DAPI, 
pseudocolored in blue.  Nucleoli (asterisks) and the heterochromatic LBC axis are well labeled 
by DAPI.  U2B” co-localizes with fluo-U2 in IGCs and on the LBC loops.  However, U2B” was 
absent from CBs (arrows) despite a strong accumulation of fluo-U2 there.  Scale bars are 5 µm. 
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Figure 2.  A model for the subnuclear trafficking and nascent transcript targeting of the U2 
snRNP.  U2 snRNAs begin assembling into snRNPs in the cytoplasm where the binding of the 
heteroheptameric ring of Sm proteins and the hypermethylation of the 5’ cap into a trimethyl 
guanosine cap (TMG) occur.  Together, The TMG and the Sm proteins promote the recruitment 
of U2 snRNAs into the nucleus.  Upon nuclear entry, the Sm site and the Sm proteins are 
sufficient for the association of  newly formed U2 snRNPs with CBs.  The interaction with CBs 
is dynamic, but at the same time internal modifications of the U2 snRNA and further assembly of 
U2 snRNPs occur within CBs.  Once SL3 and SL4 have had their protein complements fully 
assembled, U2 snRNP is prevented from associating with CBs.  Instead, it associates with IGCs 
and nascent transcripts because it possesses the necessary elements at SL3 and SL4.  Ultimately, 
U2 snRNPs take part in the assembly of the spliceosome.  
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Figure 3.  Subnuclear trafficking of the U2 snRNP is directed by discrete elements of the 
U2 snRNA.  Fluorescently labeled, full-length U2 snRNA and various mutants were and injected 
into stage IV-V oocytes.  Nuclear spreads were prepared 18 hours later and the subnuclear 
distributions of U2 snRNA and mutants were analyzed by immunofluorescence microscopy.  
Both DIC and corresponding fluorescent micrographs are shown.  Fluorescent RNAs are shown 
in green, and DNA is counterstained with DAPI, pseudocolored in red.  In the schematics of U2 
snRNA mutants, deletions are shown as red dashed lines, and the names of the secondary 
structure stem-loops, the Sm site, and the branchpoint sequence binding site (BPS) are indicated.  
Deletion of SL3 or SL4 is sufficient to prevent the association of U2 snRNA with IGCs and the 
LBC loops (nascent RNP fibrils).  Nearly half of U2 snRNA (U2∆SL1,2) can be truncated 
without affecting its intranuclear distribution.  Scale bar is 5 µm. 
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Figure 4.  The Sm site of U2 snRNA is sufficient for association with CBs.  DIC and 
corresponding fluorescent micrograph of a nuclear spread prepared 18 hours after injection of the 
chimeric RNA (pBS-U2Sm).  Fluorescent pBS-U2Sm is shown in green and DAPI is 
pseudocolored in red.  CBs are the only nuclear domains where pBS-U2Sm is detected.  Scale 
bar is 5 µm. 
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Figure 5.  U2B” must be part of a U2 snRNP to target IGCs and the nascent transcripts of 
the LBC loops.  Phase contrast and corresponding fluorescent micrographs of nuclear spreads 
prepared 18 hours after injection of (A) In-vitro transcribed HA-U2B” mRNA, and (B) HA-
U2B” mRNA and fluo-U2 snRNA, as indicated schematically.  In both cases, HA-U2B” is 
detected using the monoclonal antibody mAb 3F10 and is shown in green.  DAPI is 
pseudocolored in red.  In absence of free U2 snRNA (panel A), HA-U2B” localizes in nucleoli 
only.  In contrast, when fluo-U2 snRNA is present (panel B), HA-U2B” is only weakly 
associated with nucleoli and is readily detected in IGCs and on LBC loops.  Scale bar is 5 µm. 
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Figure 6.  U2B” is required but not sufficient for the association of U2 snRNA with IGCs 
and nascent transcripts.  U2 snRNA was depleted from oocytes by injecting the anti-sense 
DNA oligonucleotide U2b (Patel et al., 2007).  U2-depleted oocytes were then injected with 
fluo-U2, U2∆SL3 or U2∆SL4, as indicated.  Nuclear spreads were prepared 18 hours later and 
the subnuclear distributions of U2B” as well as the injected RNAs were defined by fluorescence 
microscopy.  RNAs are shown in green; endogenous U2B”, detected with mAb 4G3, is shown in 
red; DAPI is pseudocolored in blue.  Arrows indicate CBs.  Wild-type U2 and U2∆SL3 snRNAs, 
which contain SL4, display an extensive colocalization with U2B”: U2B” and U2 snRNA 
localize to IGCs and nascent transcripts, but U2∆SL3 and U2B” are restricted to CBs.  Notice 
that in both cases, U2B” is absent from nucleoli.  In the case of U2∆SL4, however, U2B” 
remains in nucleoli while U2∆SL4 accumulates in CBs.  DIC and corresponding fluorescent 
images showing groups of organelles (nucleoli are indicated by asterisks) at a higher 
magnification are also presented.  Scale bars are 5 µm. 
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Figure 7.  Disrupting the loop of SL4 inhibits IGC and nascent transcript targeting.  DIC 
and corresponding fluorescent micrographs of a nuclear spread from oocytes injected 18 hours 
earlier with fluorescent U2-L4(UUCG) snRNA.   In the U2-L4(UUCG) mutant snRNA, 
nucleotides 159-171 of SL4 were replaced with residues UUCG (shown in red).  Asterisks 
indicate critical U2B”-binding sites on SL4.  Fluorescent U2-L4(UUCG) is shown in green and 
localizes only in CBs (arrows).  In contrast, U2B”, which is detected with the mAb 4G3 (in red), 
is primarily found associated with the LBC loops and IGCs.  Notice that U2B” is barely 
detectable in nucleoli (asterisks) and CBs.  Scale bar is 5 µm. 
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Figure 8.  Artificial tethering of U2B” to U2 snRNP makes SL4 dispensable for association 
with IGCs and nascent transcripts.  DIC and corresponding fluorescent micrographs of 
nuclear spreads from oocytes 18 hours after injection with (A) Fluorescent U2ΔSL4-MS2 
snRNA, (B) in vitro-made transcripts coding for HA-MS2-U2B”, and (C) both fluorescent 
U2ΔSL4-MS2 and HA-MS2-U2B” transcripts.  Schematic diagrams of U2ΔSL4-MS2 and HA-
MS2-U2B” are shown, and the MS2 binding sequence is shown in red.  When expressed 
individually, U2ΔSL4-MS2 snRNA is detected only in CBs, while HA-MS2-U2B” associates 
only with nucleoli.  In contrast, injecting U2ΔSL4-MS2 RNA into oocytes already expressing 
HA-MS2-U2B” results in the assembly of U2ΔSL4-MS2/MS2-U2B” snRNPs that associate 
predominantly with LBC loops and IGCs and weakly with CBs (arrows).  Note that HA-MS2-
U2B” is no longer associated with nucleoli, but instead colocalizes extensively with U2ΔSL4-
MS2.  Scale bar is 5 µm. 
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Figure 9.  Artificial tethering of U2B” to the U2 snRNP rescues the co-transcriptional 
splicing activity of the mutant U2ΔSL4 snRNP.  DIC and corresponding fluorescent 
micrographs of nuclear spreads from (A) uninjected control oocytes, (B) oocytes injected the 
U2b oligonucleotide, and (C) oocytes injected with the U2b oligonucleotide, HA-MS2-U2B” 
transcripts, and fluorescent U2ΔSL4-MS2 snRNA in a temporal sequence as indicated.  The 
presence of endogenous Y14 on LBC loops, which reflects spliceosomal activity (Patel et al., 
2007), was tested using the monoclonal antibody mAb 4C4 (shown in red).  In control oocytes 
(A), but not in U2 snRNA-depleted oocytes (B), Y14 is readily detected on the chromosomal 
loops.  The expression of U2ΔSL4-MS2 snRNA and HA-MS2-U2B” in U2 snRNA-depleted 
oocytes (C) re-establishes the presence of Y14 on LBC loops, showing that U2∆SL4 can 
participate in co-transcriptional splicing.  Scale bar is 5 µm. 
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Figure 10. Recruitment of snRNPs to nascent transcripts is independent of the co-
transcriptional assembly of the spliceosome.  My data demonstrate that snRNPs are recruited 
to nascent transcripts—perhaps in a staging event—independently of spliceosomal assembly.  
SnRNPs are first recruited to nascent transcripts, possibly via interactions with hnRNPs, and 
subsequently are assembled into the spliceosome whenever its function is required. 
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Figure 11.  U2B” is detected in nuclei of Xenopus oocytes and binds specifically to wild-type 
U2 snRNA.  (A) Coimmunoprecipitation of [α-32P] labeled U2 and U2ΔSL4 snRNAs with HA-
U2B” using the αHA mAb 3F10.  100 oocytes were injected with transcripts coding for HA-
U2B” and [α-32P] labeled U2 snRNAs.  Oocytes were incubated overnight before cytoplasmic 
and nuclear fractions were harvested and separated via denaturing PAGE.  Labeled snRNAs 
were subsequently detected via phosphorimaging.  Notice that U2B” pulls down U2 snRNA 
more readily than U2ΔSL4 snRNA.  (B) Western blots of endogenous U2B” as detected by the 
mAb 4G3 and HA tagged U2B” and MS2-U2B” as detected by the mAb 3F10. 
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